CVS Health (CVS) Tops Q2 EPS by 8c; Confirms FY23 Adj EPS
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $102.05 +3.79%
EPS Growth %: +1.1%
Financial Fact:
Income tax provision: 921M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +1.1%
Financial Fact:
Income tax provision: 921M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.21, $0.08 better than the analyst estimate of $2.13. Revenue for the quarter came in at $88.92 billion versus the consensus estimate of $86.41 billion.
GUIDANCE:
CVS Health sees FY2023 EPS of $8.50-$8.70, versus the consensus of $8.59.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
